Sep. 9 at 3:16 PM
$LGVN $20 million for untapped HLHS with a TAM in US and Europe worth
$2 billion annually in revenues...not counting Alzheimer's or PDCM potential...at 30% chance of success and a 6 p/s with HLHS (
$2 billion times 6 p/s =
$12 billion times 30% chance) could value this at
$3.6 billion add another
$150 million for PDCM and Alzheimer's potential
$3.75 billion before results...Capricor and Mesoblast were both about
$2.5 billion before successful results)
